openPR Logo
Press release

Global Pharmaceutical Cartridges Market to grow at a CAGR of 7.39% to reach USD 2,693.14 million by 2032, Evaluates DelveInsight

10-31-2025 08:00 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Pharmaceutical Cartridges Market to grow at a CAGR

According to DelveInsight's analysis, The growth of the pharmaceutical cartridges market is largely fueled by the increasing prevalence of chronic diseases that require long-term and consistent medication use. Moreover, the rising trend of self-administered treatments and the growing preference for home-based healthcare are major contributors to market expansion. Technological advancements in drug delivery systems have further supported this growth by enhancing patient convenience, improving dosage precision, and promoting better treatment adherence. As a result, the pharmaceutical cartridges market is expected to witness substantial growth throughout the forecast period from 2025 to 2032.

DelveInsight's "Pharmaceutical Cartridges Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Pharmaceutical Cartridges companies actively working in the market.

To know more about why North America is leading the market growth in the Pharmaceutical Cartridges market, get a snapshot of the report Pharmaceutical Cartridges Market Trends
https://www.delveinsight.com/sample-request/pharmaceutical-cartridges-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Pharmaceutical Cartridges Overview
Pharmaceutical Cartridges are small, prefilled containers used to store and deliver liquid drugs safely and accurately. Typically made of glass or plastic, these cartridges are designed for use in injectable drug delivery systems such as pen injectors and autoinjectors. They ensure precise dosing, sterility, and convenience, making them ideal for self-administration in chronic conditions like diabetes or hormone therapy. Pharmaceutical cartridges also help reduce drug wastage and contamination risks, improving patient compliance and safety. Their growing use reflects the increasing demand for user-friendly and efficient drug delivery solutions in modern healthcare.

DelveInsight Analysis: In 2024, the pharmaceutical cartridges market size was valued at USD 1,529.59 million and is projected to grow at a CAGR of 7.39% from 2025 to 2032, reaching approximately USD 2,693.14 million by 2032.

Pharmaceutical Cartridges Market Insights
Geographically, North America is expected to dominate the pharmaceutical cartridges market, holding the largest regional share. This leadership is primarily driven by factors such as the increasing incidence of chronic diseases, the strong presence of major pharmaceutical companies, a rapidly aging population, and a highly developed healthcare infrastructure.

To read more about the latest highlights related to Pharmaceutical Cartridges, get a snapshot of the key highlights entailed in the Pharmaceutical Cartridges Market Insights
https://www.delveinsight.com/report-store/pharmaceutical-cartridges-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Pharmaceutical Cartridges Market Report
• In September 2022, SCHOTT Pharma expanded its cartridge production in China and Hungary.
• In May 2022, SCHOTT announced a double-digit million euros investment in ready-to-use cartridge production. The investment is designed to increase the production capacity of ready-to-use cartridges in St. Gallen, Switzerland.
• Thus, owing to such developments in the market, rapid growth will be observed in the Pharmaceutical Cartridges market during the forecast period

Key Players in the Pharmaceutical Cartridges Market
Some of the key market players operating in the Pharmaceutical Cartridges market include- Merck KGaA, Nipro Corporation, Stevanato Group, West Pharmaceutical Services, Inc., Gerresheimer, Schott AG, SHIOTANI GLASS CO., LTD., Dätwyler Holding Inc., Shandong Province Medicinal Glass Co., Ltd., Adelphi Healthcare Packaging, and others.

Which MedTech key players in the Pharmaceutical Cartridges market are set to emerge as the trendsetter explore @ Key Pharmaceutical Cartridges Companies
https://www.delveinsight.com/sample-request/pharmaceutical-cartridges-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Pharmaceutical Cartridges Market Landscape
Furthermore, amber-colored glass cartridges provide protection against ultraviolet (UV) light, preventing photodegradation of light-sensitive medications. This property is especially beneficial for drugs that require long-term stability during storage and transport under varying environmental conditions.
In addition, glass cartridges possess strong mechanical durability, making them suitable for automated filling processes and minimizing breakage risks during handling. Owing to their strength, scalability, and widespread regulatory approval, glass cartridges are increasingly preferred by pharmaceutical manufacturers.
Consequently, factors such as chemical inertness, UV resistance, environmental durability, and regulatory compliance are expected to drive significant growth in the glass segment, contributing to the overall expansion of the pharmaceutical cartridges market from 2025 to 2032.

Scope of the Pharmaceutical Cartridges Market Report
• Coverage: Global
• Study Period: 2022-2032
• Pharmaceutical Cartridges Market Segmentation By Type: Glass {Type 1, Type 2, and Type 3} and Plastic
• Pharmaceutical Cartridges Market Segmentation By End-User: Pharma and Biotech Companies and Other End-Users
• Pharmaceutical Cartridges Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Pharmaceutical Cartridges Companies: Merck KGaA, Nipro Corporation, Stevanato Group, West Pharmaceutical Services, Inc., Gerresheimer, Schott AG, SHIOTANI GLASS CO., LTD., Dätwyler Holding Inc., Shandong Province Medicinal Glass Co., Ltd., Adelphi Healthcare Packaging, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Pharmaceutical Cartridges market will grow by 2032? Click to get a snapshot of the Pharmaceutical Cartridges Market Analysis
https://www.delveinsight.com/sample-request/pharmaceutical-cartridges-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pharmaceutical Cartridges Market to grow at a CAGR of 7.39% to reach USD 2,693.14 million by 2032, Evaluates DelveInsight here

News-ID: 4249159 • Views:

More Releases from DelveInsight Business Research

Retinitis Pigmentosa Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight
Retinitis Pigmentosa Pipeline 2026: FDA Approvals and Clinical Trials Landscape …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Retinitis Pigmentosa pipeline constitutes 20+ key companies continuously working towards developing 25+ Retinitis Pigmentosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Retinitis Pigmentosa Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Retinitis Pigmentosa Market. The Retinitis
Multiple Sclerosis Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Multiple Sclerosis Pipeline 2026: Therapies, MOA Insights, and Key Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Multiple Sclerosis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also
Car T Cell Therapy For Multiple Myeloma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight
Car T Cell Therapy For Multiple Myeloma Pipeline 2026: MOA, ROA, FDA-Approved Dr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Car T Cell Therapy For Multiple Myeloma pipeline constitutes 5+ key companies continuously working towards developing 5+ Car T Cell Therapy For Multiple Myeloma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Car T Cell Therapy For Multiple Myeloma Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into
Spinocerebellar Ataxias Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight
Spinocerebellar Ataxias Pipeline 2026: Therapies Under Investigation, Clinical T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Spinocerebellar Ataxias Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market. The Spinocerebellar

All 5 Releases


More Releases for Pharma

Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring